Scientists Present the Advantages of a New Therapy Study against Choroid Plexus
Scientists from the M. D. Anderson Cancer Center within The University of Texas underwent the biggest collaboration research that observed a rare brain tumor that affects children. The results of the investigation present a new protocol which may increase the survival range in children suffering from choroid plexus tumors. The study was released during the Annual Meeting of the International Society of Pediatric Oncology at its 41st edition. The finances for this research came from the German Children’s Cancer Foundation.
Leading the research was professor doctor Johannes Wolff from the Children’s Cancer Hospital within the M. D. Anderson Cancer Center. He stated that the new protocol comprises three chemotherapy factors and irradiation and forecasts a rate of survival of 93% for the first year, 83% in the next five and 78% in eight years.
As Doctor Wolff explains the research began a decade ago and was entitled SIOP 2000. Since its early beginnings, the project expanded and now comprises over 100 institutions located in over 20 countries. Due to this amalgam of cultures and institutions, the researchers were able to examine huge amounts of data and are now able to say which ill persons are going to improve their health and which ones have small chances of recovery. Moreover, the team of investigators managed to develop a standard protocol for the children with low expectancy of survival.
The malignant tumors entitled choroid plexus affect the brain. Their origin is in the choroid plexus epithelium which represents an important element for the human body since it is the agent that creates the cerebrospinal fluid. In the majority of the cases, the malignant tumors block the free flow of the cerebrospinal fluid, an action which produces pressure in the brain and may lead to an enlarged skull. This condition is a very rare type of cancer which affects almost 1,500 children per year all over the Globe. The majority of the cases are encountered in infants.
The international team of investigators desire to find new methods of therapy to counteract the choroid plexus, but this is a hard job due to the rarity of this condition. There are not any standard therapeutic mechanisms to combat these malign tumors. However, the scientists did not give up and managed to create a brand new statistical model in order for the institutions to acquire high quality and effective data provided by the research.
Surprisingly, Wolff`s international team found a rather shocking thing which was in complete contradiction with the traditional practices in the cases of choroid plexus suffering patients. If it was customary in the past to treat this illness by surgery and total resection of the malignant tumor, the SIOP 2000 investigation showed that children who were treated with aggressive chemotherapy showed almost the same results as the ones that underwent surgery. This finding meant that the stressful surgery protocol was not a major element in treating the choroid plexus and diminished the need to undergo operation.
As Doctor Wolff states that they have a hypothesis rising from the cases in which the medical doctors extended the time span for chemotherapy in children. If it proves to be correct, the team`s hypothesis may provide a reason for prolonging the chemo treatment for a longer period of time.
Moreover, the leading author of the study says that the next phase of the research is to undergo another investigation in a four-armed chemo treatment. By doing this, the scientists would examine the opportunity of bringing another chemo so as to enhance the survival time span for children. The chemotherapy protocols used in the SIOP 2000 research comprised irradiation, carboplatinum, etoposide and cyclophosamide.
